Lv1
10 积分 2024-05-14 加入
Development of Dual FLT3 and CHK1 PROTACs for the Treatment of AML
1天前
待确认
Discovery of SILA-123 as a Highly Potent FLT3 Inhibitor for the Treatment of Acute Myeloid Leukemia with Various FLT3 Mutations
2个月前
已完结
Metabolic communication in the tumour–immune microenvironment
6个月前
已完结
Indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors and PROTAC-based degraders for cancer therapy
6个月前
已完结
Metabolic communication in the tumour–immune microenvironment
6个月前
已完结
Journey of PROTAC: From Bench to Clinical Trial and Beyond
9个月前
已完结
Serotonin a la carte: Supplementation with the serotonin precursor 5-hydroxytryptophan
10个月前
已完结
Characterization of the human homolog of the IL-4 induced gene-1 (Fig1)
1年前
已完结
Mitochondrial Protease Targeting Chimeras for Mitochondrial Matrix Protein Degradation
1年前
已完结
Microbial metabolite enhances immunotherapy efficacy by modulating T cell stemness in pan-cancer
1年前
已完结
皖公网安备34019202002308
